Sturge-Weber Syndrome

A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.

Drugs by status

Phase 3 trials (1)

sirolimus

Phase 2 trials (3)

cannabidiol
everolimus
qls-101

Phase 1 trials (1)

timolol

Organizations

Organization Involved with Phase 3 Indications (5)

Pfizer
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
University of Cincinnati

Organization Involved with Phase 2 Indications (5)

Novartis
GW Pharmaceuticals Ltd.
Baylor University
Clinica Universidad de Navarra
Faneca 66 Foundation

Organization Involved with Phase 1 Indications (2)

Thomas Jefferson University
University of Medicine and Dentistry of New Jersey

ICD-10 crosswalk

Q85.8 — Other phakomatoses, not elsewhere classified